Back to Resources
Market Highlights
- The Q3 2025 European glucose monitors market mostly produced core sales aids and DTC materials, while print pieces surpassed digital promotions. Overall, the market was driven by continuous glucose monitoring, digital tools, better clinical results, and expanded access across diverse patient groups.
- Abbott emphasized improved glycemic control with its FreeStyle Libre 2 Plus and 3 Plus systems across Europe. Products offered 15-day wear, real-time monitoring, insulin pump integration, and extensive digital support. It utilized educational tools, such as LibreView for patient and HCP support.
- Ascensia promoted Contour as Germany’s leading glucose meter, praised for its accuracy and ease of use. The campaign focused on simplifying self-monitoring.
- Dexcom showcased its G7 and ONE+ CGMs across Europe, offering non-scan, predictive alerts and seamless connectivity. G7’s integration and compatibility with other devices enhanced flexibility. Dexcom ONE+ replaced Dexcom ONE on select formularies.
- Medtronic’s MiniMed 780G earned expanded CE approval in Germany for certain populations. Simplera Sync shortages led to the temporary use of Guardian 4 sensors.
- Roche launched the Accu-Chek SmartGuide CGM in Germany with AI-powered glucose forecasting and real-time smartphone data. Approved for T1D and T2D, it provided simplicity, predictive care, and regulatory readiness.
Questions about this SnapShot or other markets?
U.S. MARKETS
Christine Alongi
alongi@dtwresearch.com
GLOBAL MARKETS
Robin Cefalo
cefalo@dtwresearch.com
SOCIAL MEDIA MARKETS
Andrew Carney
carney@dtwresearch.com